Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Deborah J. Wexler MD, MSc Associate Editor

Richard E. Pratley MD Associate Editor

See All Experts

story of the week

Published in Diabetes

Journal Scan / Research · March 16, 2023

Trends in the Incidence of Youth-Onset Type 1 and Type 2 Diabetes in the US

The Lancet Diabetes & Endocrinology

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Additional Info

Article Citation

The Lancet Diabetes & Endocrinology

Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002-18: results from the population-based SEARCH for Diabetes in Youth study

Lancet Diabetes Endocrinol 2023 Feb 28;[EPub Ahead of Print], LE Wagenknecht, JM Lawrence, S Isom, ET Jensen, D Dabelea, AD Liese, LM Dolan, AS Shah, A Bellatorre, K Sauder, S Marcovina, K Reynolds, C Pihoker, G Imperatore, J Divers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Trends in the Incidence of Youth-Onset Type 1 and Type 2 Diabetes in the US

Additional Info

Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002-18: results from the population-based SEARCH for Diabetes in Youth study

Further Reading

Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes — 2025

Efficiency of CGM in Predicting Gestational Diabetes and Perinatal Complications

Effect of Sarcopenic Obesity on the Progression of Glycaemic Status in Middle-Aged and Older Adults Without Diabetes

Use of SGLT2 Inhibitors Reduces Epicardial Adipose Tissue More Effectively Compared With GLP-1 Agonists or Exercise in Patients With Type 2 Diabetes and/or Obesity

Prevalence of Metabolic Syndrome Among Children and Adolescents With Obesity

Improving Care and Promoting Health in Populations: Standards of Care in Diabetes — 2025

Perinatal Outcomes in Patients With Early vs Late Gestational Diabetes Mellitus Treated Between 24 and 28 Weeks of Gestation

Association Between Bone Mineral Density and the Risk of Kidney Disease Progression in Patients With Type 1 Diabetes

Role of Intermittent Fasting in Weight Management and Improving Metabolic Health

Consensus Considerations and Good Practice Points for the Use of CGM Systems in Hospital Settings

Weight Changes After Treatment With Semaglutide in Individuals With MASLD/MASH With or Without Type 2 Diabetes

Recently Updated